Home » Topics » Disease categories and therapies » Urology

Urology
RSS

American Home Products patents selective, orally active, nonpeptide V2 agonists

March 24, 1999

Piperazine derivatives for lower urinary tract disorders designed at Recordati

March 23, 1999

Ono-4057: BLT receptor antagonist with beneficial effects in rat model of nephritis

March 22, 1999

TGF-beta inhibitors for nephritis disclosed by Tsumura

March 16, 1999

Zeria patents new series for BPH

March 15, 1999

Orally active, selective V2 agonists in development at AHP

March 12, 1999

Recordati claims potent and selective 5-HT1A receptor antagonists for urinary disorders

March 12, 1999

New Drug Submission for Ditropan accepted for review in Canada

March 10, 1999

Microbially produced 5alpha-reductase inhibitor discovered at Snow Brand

March 9, 1999

Licensing opportunity from VUFB: alpha2-adrenoceptor antagonist for BPH and heart failure

Feb. 16, 1999

Popular Stories

University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Beijing Innocare Pharma Tech discloses new GSPT1 degradation inducers
BioWorld Science
Beijing Innocare Pharma Tech Co. Ltd. has synthesized new antibody-drug conjugates comprising antibody or antigen-binding fragment covalently linked to eukaryotic...